Kingdon Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-50,000
Closed -$17.2M 90
2023
Q1
$17.2M Buy
+50,000
New +$16.9M 3.23% 8
2018
Q4
Sell
-300,000
Closed -$32.2M 82
2018
Q3
$32.2M Buy
+300,000
New +$30M 2.25% 9

Other funds holding LLY

Kingdon Capital Management's LLY Position: Q4 2015 in Review

Kingdon Capital Management sold out of Eli Lilly (LLY) in Q4 2015, closing a stake of 61,100 shares — an estimated $5.11M sold.

Kingdon Capital Management first reported a position in LLY in Q3 2015 and held it in 1 quarter. The position peaked at $5.11M in Q3 2015. 1,221 funds tracked by Wall St. Rank hold LLY as of Q4 2015.

  • Kingdon Capital Management reported no remaining Eli Lilly position as of Q4 2015 after selling out during the quarter.
  • Kingdon Capital Management sold 61,100 Eli Lilly shares in Q4 2015, an estimated $5.11M.
  • Kingdon Capital Management first reported a position in Eli Lilly in Q3 2015 and held it in 1 quarter.
  • Kingdon Capital Management's Eli Lilly position peaked at $5.11M in Q3 2015.
  • 1,221 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2015.

Based on Kingdon Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.